These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34617209)

  • 21. Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.
    Bokkers K; Bleiker EMA; Hoogendam JP; Velthuizen ME; Schreuder HWR; Gerestein CG; Lange JG; Louwers JA; Koudijs MJ; Ausems MGEM; Zweemer RP
    Hered Cancer Clin Pract; 2022 Sep; 20(1):33. PubMed ID: 36076240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country.
    Lee YQ; Yoon SY; Hassan T; Padmanabhan H; Yip CH; Keng WT; Thong MK; Ahmad Annuar MA; Mohd Taib NA; Teo SH
    J Genet Couns; 2022 Oct; 31(5):1080-1089. PubMed ID: 35481858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer.
    Sadinsky MB; Power J; Ambrosio E; Palma L; Zeng X; Foulkes WD; Weber E
    Curr Oncol; 2022 May; 29(5):3565-3575. PubMed ID: 35621678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of germline pathogenic
    Morgan RD; Burghel GJ; Flaum N; Bulman M; Clamp AR; Hasan J; Mitchell CL; Schlecht H; Woodward ER; Lallo FI; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR
    J Med Genet; 2019 May; 56(5):301-307. PubMed ID: 30683677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologist-led
    Yoon SY; Wong SW; Lim J; Ahmad S; Mariapun S; Padmanabhan H; Hassan NT; Lau SY; Ch'ng GS; Haniffa M; Ong WP; Rethanavelu K; Moey LH; Keng WT; Omar J; Mohd Abas MN; Yong CM; Ramasamy V; Md Noor MR; Aliyas I; Lim MCK; Suberamaniam A; Mat Adenan NA; Ahmad ZA; Ho GF; Abdul Malik R; Subramaniam S; Khoo BP; Raja A; Chin YS; Sim WW; Teh BH; Kho SK; Ong ESE; Voon PJ; Ismail G; Lee CL; Abdullah BZ; Loo KS; Lim CS; Lee SJ; Lim KJL; Shafiee MN; Ismail F; Latiff ZA; Ismail MP; Mohamed Jamli MF; Kumarasamy S; Leong KW; Low J; Md Yusof M; Ahmad Mustafa AM; Mat Ali NH; Makanjang M; Tayib S; Cheah N; Lim BK; Fong CK; Foo YC; Mellor Abdullah M; Tan TS; Chow DSY; Ho KF; Raman R; Radzi A; Deniel A; Teoh DCY; Ang SF; Joseph JK; Ng PHO; Tho LM; Ahmad AR; Muin I; Bleiker E; George A; Thong MK; Woo YL; Teo SH
    J Med Genet; 2022 Mar; 59(3):220-229. PubMed ID: 33526602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
    Eccles DM; Balmaña J; Clune J; Ehlken B; Gohlke A; Hirst C; Potter D; Schroeder C; Tyczynski JE; Gomez Garcia EB
    Adv Ther; 2016 Feb; 33(2):129-50. PubMed ID: 26809252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.
    Bokkers K; Vlaming M; Engelhardt EG; Zweemer RP; van Oort IM; Kiemeney LALM; Bleiker EMA; Ausems MGEM
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205807
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kansu B; Gardner J; Price-Tate R; Murch O; Murray A
    J Obstet Gynaecol; 2021 Aug; 41(6):962-965. PubMed ID: 33228436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian Cancers in Pakistan.
    Tariq H; Gul A; Khadim T; Ud-Din H; Tipu HN; Asif M; Ahmed R
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):719-724. PubMed ID: 33773534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals.
    van der Giessen J; Fransen MP; Spreeuwenberg P; Velthuizen M; van Dulmen S; Ausems MGEM
    J Community Genet; 2021 Jan; 12(1):91-99. PubMed ID: 33319336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
    Jorge S; McFaddin AS; Doll KM; Pennington KP; Norquist BM; Bennett RL; Pritchard CC; Swisher EM
    Gynecol Oncol; 2020 Mar; 156(3):517-522. PubMed ID: 31883735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
    Tone AA; McCuaig JM; Ricker N; Boghosian T; Romagnuolo T; Stickle N; Virtanen C; Zhang T; Kim RH; Ferguson SE; May T; Laframboise S; Armel S; Demsky R; Volenik A; Stuart-McEwan T; Shaw P; Oza A; Kamel-Reid S; Stockley T; Bernardini MQ
    Gynecol Oncol; 2021 Jul; 162(1):97-106. PubMed ID: 33858678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.
    Sunar V; Korkmaz V; Topcu V; Cavdarli B; Arik Z; Ozdal B; Ustun YE
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):84-92. PubMed ID: 33629534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FLABRA, frontline approach for
    Giornelli G; Gallardo D; Hegg R; Abuin GG; La Vega M; Lim-Law M; Caceres V; Trujillo L; Pilar Estevez-Diz MD; Pacheco C; Sganga L; Goncalves S
    Future Oncol; 2021 May; 17(13):1601-1609. PubMed ID: 33415992
    [No Abstract]   [Full Text] [Related]  

  • 37. British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for
    Sundar S; Manchanda R; Gourley C; George A; Wallace A; Balega J; Williams S; Wallis Y; Edmondson R; Nicum S; Frost J; Attygalle A; Fotopoulou C; Bowen R; Bell D; Gajjar K; Ramsay B; Wood NJ; Ghaem-Maghami S; Miles T; Ganesan R
    Int J Gynecol Cancer; 2021 Feb; 31(2):272-278. PubMed ID: 33468564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating an online training module on protecting children from secondhand smoke exposure: impact on knowledge, confidence and self-reported practice of health and social care professionals.
    Jones LL; McEwen A
    BMC Public Health; 2015 Nov; 15():1132. PubMed ID: 26573632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
    Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inadequate Rates of BRCA Testing with its Negative Consequences for Women with Epithelial Ovarian Cancer and their Families: an Overview of the Literature.
    Hoskins PJ
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):472-483. PubMed ID: 29735311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.